Any response *other* than a full demonstration of a functional, commercialized product, resulting in the SEC dropping all penalties and the FDA moving to approve... would be completely expected.
Anything less, is just DECN being DECN.
(1)
(1)
Decision Diagnostics Corp (DECN) Stock Research Links
